Royal Bank of Canada Reiterates Outperform Rating for agilon health (NYSE:AGL)

Royal Bank of Canada reissued their outperform rating on shares of agilon health (NYSE:AGL) in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a $3.00 price target on the stock.

AGL has been the topic of several other reports. Barclays lowered their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Benchmark reaffirmed a “buy” rating and set a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $6.05.

agilon health Stock Up 1.3 %

agilon health stock opened at $1.59 on Tuesday. The stock has a market cap of $655.11 million, a P/E ratio of -1.69 and a beta of 0.60. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a twelve month low of $1.50 and a twelve month high of $13.76. The company’s 50-day moving average price is $2.97 and its two-hundred day moving average price is $4.81.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period in the prior year, the company earned ($0.06) earnings per share. As a group, analysts expect that agilon health will post -0.47 EPS for the current year.

Insider Buying and Selling at agilon health

In related news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 42.03 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Several large investors have recently modified their holdings of AGL. Capital International Investors raised its stake in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after acquiring an additional 9,263,296 shares during the last quarter. Citigroup Inc. raised its stake in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after acquiring an additional 1,316,990 shares during the last quarter. Quantbot Technologies LP bought a new position in shares of agilon health during the third quarter valued at $1,742,000. Finally, Vanguard Group Inc. raised its stake in shares of agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after acquiring an additional 371,537 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.